Tatva Chintan Pharma Chem Limited (TATVA) — Corporate Action | 11 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Final dividend of ₹2.00 per share approved for FY 2025-26, payable post-AGM approval.
🔄 What Changed
Dividend rate of 20% declared on Rs 10 face value; TDS compliance requirements updated with new deadlines and documentation for treaty benefit claims.
🔮 What's Next
Payment contingent on shareholder approval at AGM; documentation deadline of 10 September 2026 for tax benefit claims.
💡 Investor Takeaway
Shareholders must submit updated tax documents by 10 September 2026 to claim lower tax rates or exemptions on the ₹2.00 dividend.

Tatva Chintan Pharma Chem announced a final dividend of ₹2.00 per share (20% on a Rs 10 face value) for FY 2025-26, payable after shareholder approval at the upcoming AGM, with board approval dated 16 May 2026. Shareholders must submit updated PAN, email, and bank details by 10 September 2026 to claim treaty benefits or lower tax rates, including Form 121 or Section 395(1) certificates for reduced withholding. Non-residents face a standard 20% plus surcharge and cess rate unless exemptions apply. The filing mandates compliance with tax residency declarations, indemnification for incorrect claims, and strict documentation to avoid denial of treaty benefits under DTAA and anti-avoidance rules.

📄 View Original Announcement (PDF)

About Tatva Chintan Pharma Chem Limited (TATVA)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹3,079.1 Cr P/E: 215.4

View full TATVA stock details →

📡 Get AI alerts when TATVA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TATVA — Free

📊 More TATVA filings

See all TATVA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TATVA files new disclosures

Track TATVA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TATVA — Free

Free account · 2 AI queries/day